American Journal of Cardiology
Volume 102, Issue 9 , Pages 1131-1135 , 1 November 2008

Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)

  • Mintu P. Turakhia, MD

      Affiliations

    • Department of Medicine, University of California, San Francisco, California
    • Section of Cardiac Electrophysiology, Stanford University, Stanford, California
    • Corresponding Author InformationCorresponding author: Tel: 650-724-0988; fax: 650-725-7568
    • ,
  • Nelson B. Schiller, MD, FACC

      Affiliations

    • Department of Medicine, University of California, San Francisco, California
    • ,
  • Mary A. Whooley, MD

      Affiliations

    • Department of Medicine, University of California, San Francisco, California
    • Department of Epidemiology and Biostatistics, University of California, San Francisco, California
    • Section of General Internal Medicine, VA Medical Center, San Francisco, California

Received 5 May 2008 ,Revised 30 June 2008 ,Accepted 30 June 2008.

References 

  1. Gardin J, McClelland R, Kitzman D, Lima J, Bommer W, Klopfenstein H, et al. M-Mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001;87:1051–1057
  2. Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001;38:1829–1835
  3. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454–1459
  4. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222–1230
  5. Lavie CJ, Milani RV, Ventura HO, Messerli FH. Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol. 2006;98:1396–1399
  6. Ruo B, Rumsfeld J, Hlatky M, Liu H, Browner W, Whooley M. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290:215–221
  7. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al Recommendations for quantitation of the left ventricle by two-dimensional echocardiography (American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms). J Am Soc Echocardiogr. 1989;2:358–367
  8. Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  9. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7:639–650
  10. Ang D, Pringle S, Struthers A. The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris. Am J Hypertens. 2007;20:1029–1035
  11. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–526
  12. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–241
  13. Stecker E, Vickers C, Waltz J, Socoteanu C, John B, Mariani R, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161–1166
  14. Singh J, Hall W, McNitt S, Wang H, Daubert J, Zareba W, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol. 2005;46:1712–1720
  15. Choudhury L, Mahrholdt H, Wagner A, Choi K, Elliott M, Klocke F, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156–2164
  16. Moon J, McKenna W, McCrohon J, Elliott P, Smith G, Pennell D. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561–1567
  17. Spirito P, Bellone P, Harris K, Bernabo P, Bruzzi P, Maron B. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–1785
  18. Barbier CE, Bjerner T, Johansson L, Lind L, Ahlstrom H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48:765–771
  19. Kon-No Y, Watanabe J, Koseki Y, Koyama J, Yamada A, Toda S, et al. Microvolt T wave alternans in human cardiac hypertrophy: electrical instability and abnormal myocardial arrangement. J Cardiovasc Electrophysiol. 2001;12:759–763

 Dr. Turakhia was supported by grants from the American College of Cardiology and Merck Foundation. The Heart and Soul Study was supported by the Department of Veterans Affairs, the National Heart, Lung and Blood Institute (R01 HL079235), the American Federation for Aging Research, the Robert Wood Johnson Foundation, and the Ischemia Research and Education Foundation.

PII: S0002-9149(08)01138-7

doi: 10.1016/j.amjcard.2008.06.036

American Journal of Cardiology
Volume 102, Issue 9 , Pages 1131-1135 , 1 November 2008

Article Tools

* Image Usage & Resolution